Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,809 | 30,175 | 33,589 | 37,285 | 41,046 |
| Receivables | 5,180 | 4,238 | 3,637 | 3,819 | 3,266 |
| Inventories | 14,611 | 12,929 | 14,062 | 12,715 | 11,877 |
| TOTAL | $43,783 | $49,354 | $52,654 | $55,340 | $57,749 |
| Non-Current Assets | |||||
| PPE Net | 1,244 | 1,067 | 889 | 916 | 693 |
| Intangibles | 2,926 | 2,926 | 2,926 | 2,926 | 2,926 |
| Other Non-Current Assets | 2,289 | 1,937 | 2,045 | 2,067 | 2,116 |
| TOTAL | $6,459 | $5,930 | $5,860 | $5,909 | $5,735 |
| Total Assets | $50,242 | $55,284 | $58,514 | $61,249 | $63,484 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,400 | 700 | N/A |
| Accounts payable and accrued liabilities | 4,643 | 3,309 | 3,597 | 3,502 | 3,072 |
| Accrued Expenses | 6,027 | 8,276 | 6,182 | 6,461 | 6,237 |
| TOTAL | $13,112 | $13,844 | $13,457 | $12,719 | $11,270 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,666 | 13,603 | 12,114 | 12,703 | 16,295 |
| Deferred Revenues | 2,442 | 2,259 | 2,278 | 2,056 | 1,961 |
| Other Non-Current Liabilities | 2,561 | 2,300 | 2,327 | 2,238 | 2,060 |
| TOTAL | $16,530 | $16,232 | $14,735 | $15,274 | $18,698 |
| Total Liabilities | $29,642 | $30,076 | $28,192 | $27,993 | $29,968 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62 | 62 | 61 | 60 | 60 |
| Common Shares | 155 | 6 | 153 | 151 | 149 |
| Retained earnings | -272,310 | -267,534 | -262,255 | -258,979 | -258,277 |
| Other shareholders' equity | -664 | -623 | -558 | -468 | -533 |
| TOTAL | $20,600 | $25,208 | $30,322 | $33,256 | $33,516 |
| Total Liabilities And Equity | $50,242 | $55,284 | $58,514 | $61,249 | $63,484 |